Performance of an adipokine pathway-based multilocus genetic risk score for prostate cancer risk prediction.
Few biomarkers are available to predict prostate cancer risk. Single nucleotide polymorphisms (SNPs) tend to have weak individual effects but, in combination, they have stronger predictive value. Adipokine pathways have been implicated in the pathogenesis. We used a candidate pathway approach to inv...
Guardado en:
Autores principales: | Ricardo J T Ribeiro, Cátia P D Monteiro, Andreia S M Azevedo, Virgínia F M Cunha, Agnihotram V Ramanakumar, Avelino M Fraga, Francisco M Pina, Carlos M S Lopes, Rui M Medeiros, Eduardo L Franco |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6328e273a3604ed0b6499cdddb261525 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of prostate health index to predict Gleason score upgrading and high-risk prostate cancer in radical prostatectomy specimens
por: Hwanik Kim, et al.
Publicado: (2021) -
A Polygenic Risk Score Predicts Incident Prostate Cancer Risk in Older Men but Does Not Select for Clinically Significant Disease
por: Andrew Bakshi, et al.
Publicado: (2021) -
Effect of weight loss on adipokine levels in obese patients
por: Hession M, et al.
Publicado: (2011) -
Risk score to stratify miscarriage risk levels in preconception women
por: Xin Hui Choo, et al.
Publicado: (2021) -
Risk analysis of systemic levels of estrogen and adipokines as well as estrogen receptors from PBMCs in childbearing and perimenopausal women with obesity
por: Fan H, et al.
Publicado: (2019)